Delving into the Latest Updates on Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms

Influenza A virus H5N1 vaccine (Denka Seiken Co., Ltd.), Adsorbed Influenza Vaccine

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

Influenza A virus infection

Inactive Indication-

Originator Organization

Denka Seiken Co., Ltd.

Active Organization

Denka Seiken Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhaseApproved

First Approval Date-

Regulation-

Login to view timeline

Experimental batches of adsorbed subunit influenza vaccine were prepared from the envelope of glycoprotein antigens separated from the influenza virion by treatment with a cationic detergent (cetyltrimethylammonium bromide). Purified and concentrated influenza virus strains A(H1N1) and A(H3N2) were obtained by gradient centrifugation; additional purification, with a view to removing ovalbumin and structural components of the chorioallantoic membrane, was achieved by gelfiltration. The composition and biological properties of the vaccine are described.

100 Deals associated with Influenza A virus H5N1 vaccine(Denka Seiken Co., Ltd.)

Login to view more data